Research Article
Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer
Table 3
Univariate and multivariate analyses of CCND1 expression in BCR-free survival time analysis.
| Univariate | BCR-free survival time | HR (95% CI) | |
| Low IE score (cytoplasmic) | 1 | | High IE score (cytoplasmic) | 0.536 (0.362-0.793) | 0.002 | Low IE score (nuclear) | 1 | | High IE score (nuclear) | 0. 816 (0.561-1.186) | 0.286 | Multivariate | | | IE score (cytoplasmic) (low/high) | 0.774 (0.504-1.189) | 0.242 | pT stage (pT2/pT3, pT4) | 1.736 (1.128-2.672) | 0.012 | pN stage (pNx, pN0/pN1) | 2.560 (1.576-4.159) | <0.001 | Gleason score () | 2.011 (1.337-3.026) | 0.001 | PSA level () | 2.096 (1.147-3.829) | 0.016 |
|
|